PHAT financials
Phathom Pharmaceuticals (PHAT) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
PHAT income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $175.11M | $152.51M | -$159.99M | -$221.25M | -3.03 |
| 2024 | $55.25M | $47.28M | -$277.47M | -$334.33M | -5.29 |
| 2023 | $682.00K | $515.00K | -$167.31M | -$201.59M | -3.93 |
| 2022 | $0.00 | -$620.00K | -$172.44M | -$197.72M | -5.70 |
| 2021 | $0.00 | -$521.00K | -$135.08M | -$143.88M | -4.00 |
| 2020 | $0.00 | -$300.00K | -$125.67M | -$129.07M | -4.01 |
- PHAT revenue was $175.11M in fiscal 2025, net income -$221.25M.
Updated 2026-11-03 04:21 UTC